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Abstract 
Efficient drug delivery to the skin is essential for the treatment of major dermatologic diseases, such as 
eczema, psoriasis and acne. However, many compounds penetrate the skin barrier poorly and require 
optimized formulations to ensure their bioavailability. Here, stimulated Raman scattering (SRS) 
microscopy, a recently-developed, label-free chemical imaging tool, is used to acquire high resolution 
images of multiple chemical components of a topical formulation as it penetrates into mammalian skin. 
This technique uniquely provides label-free, non-destructive, three-dimensional images with high 
spatiotemporal resolution. It reveals novel features of (trans)dermal drug delivery in the tissue 
environment: different rates of drug penetration via hair follicles as compared to the intercellular 
pathway across the stratum corneum are directly observed, and the precipitation of drug crystals on the 
skin surface is visualized after the percutaneous penetration of the co-solvent excipient in the 
formulation. The high speed three-dimensional imaging capability of SRS thus reveals features that 
cannot be seen with other techniques, providing both kinetic information and mechanistic insight into 
the (trans)dermal drug delivery process. 
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Introduction 
While the barrier properties of human skin are essential to life, the low permeability of this 
membrane to many compounds means that topical drug delivery to treat dermatological disease is very 
challenging1. To optimize the transport of skin-active compounds, analytical methods are required to 
determine the rate and extent of absorption into and through the barrier. At present, a widely-used 
approach involves adhesive tape-stripping2, in which the outermost layer of skin (the stratum corneum 
(SC), which constitutes the principal barrier) is progressively removed and then analyzed chemically to 
produce the drug’s concentration profile across the membrane. In contrast, an ideal technique would 
enable relevant measurements in mammalian skin and provide label-free, nondestructive analysis with 
high spatial and temporal resolution. Here, we demonstrate that stimulated Raman scattering (SRS) 
microscopy3-7, a recently-developed imaging technique (Figure 1), is an ideal tool for this purpose, 
because it offers high sensitivity and high spatial resolution imaging of chemical distributions without the 
use of exogenous fluorescent labels. 
Figure 1A shows the energy diagram of SRS. Two laser beams with frequencies ωp (the pump 
beam) and ωS (the Stokes beam) have a difference frequency ωp-ωS that matches an intrinsic molecular 
vibrational frequency in the sample at ωvib. The SRS process transfers intensity from the pump beam to 
the Stokes beam and excites the vibrational resonance of the sample from the ground state (υ=0) to the 
first vibrational excited state (υ =1).  Figure 1B then illustrates the principle of modulation transfer 
detection: Before the sample, the pump laser pulse train is unmodulated while the Stokes laser pulse 
train is modulated at a reference frequency of 10 MHz. After both beams interact with the sample, the 
Stokes beam is blocked by an optical filter and the pump beam is detected by a photodiode and lock-in 
amplifier. Because SRS only occurs when both beams are present, amplitude modulation of the Stokes 
beam is transferred to the pump beam (because SRS removes intensity from the pump beam) and can be 
sensitively detected. 
In this work, two non-steroidal anti-inflammatory drugs, ibuprofen and ketoprofen, were 
evaluated following their topical application as solutions in propylene glycol (PG), a common co-
solvent/excipient used in a wide variety of pharmaceutical, cosmetic and personal care formulations1. 
For SRS imaging, ketoprofen had a strong vibrational resonance from aromatic CH bond stretching at 
~1599 cm-1, while deuteration of PG and ibuprofen created unique vibrational resonances at 
approximately 2120 cm-1. These Raman signals were easily distinguished (with minimal cross-talk given 
the ~5 cm-1 spectral resolution of the picosecond SRS imaging system used) from the strong spectral 
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fingerprint emanating from skin lipids, including those in the intercellular domains of the stratum 
corneum and those secreted by sebaceous glands (Figure 1C). 
 
Figure 1: Principle of SRS microscopy detection. (A) The energy diagram. During the SRS process, light is 
transferred from the pump beam to the Stokes beam, and the sample is vibrationally-excited. (B) 
Principle of modulation transfer detection. (C) Raman spectra used in this work. The contrast in SRS is 
based on the spontaneous Raman spectra, which are used to determine the optimal excitation 
wavelengths for SRS.  
 
Experimental Section 
Solution Preparation. Ketoprofen (≥ 98% TLC), ibuprofen-d3 (≥ 98% HPLC), propylene glycol (≥ 99.5% GC) 
and propylene glycol-d8 (98 atom %D), were obtained from Sigma-Aldrich (Gillingham, Dorset, UK). For 
the experiments with ketoprofen, the drug was dissolved in propylene glycol-d8 at a concentration of 180 
mg ml-1; i.e., at ~90% of its reported saturation solubility8 of approximately 199 mg ml-1. In the ibuprofen 
experiments, the deuterated drug was dissolved in (‘normal’, undeuterated) PG at a concentration of 
380 mg ml-1, which again represents about 90% of the published solubility (~430 mg ml-1)9. 
Raman Spectroscopy. Raman spectra (Figure 1C) of mouse skin and of the chemicals used in the study 
were acquired using a commercial Raman microspectrometer (LabRam HR, Horiba Jobin Yvon) with 633 
nm excitation and detection via an open-electrode charge coupled device camera linked to a 750 mm 
focal length dispersive polychromator.  
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Sample Preparation. For imaging experiments, 7-9 week old BALB/c mice were purchased from a 
commercial supplier (Taconic) and housed in OAR-style facilities according to Harvard FAS IACUC 
Protocol #29-01. They were sacrificed using asphyxiation by CO2 followed by cervical dislocation. All 
measurements reported here are performed ex vivo. The solutions were applied in a 25 μl aliquot to a 
small portion of an ear (~10 mm2). The ear was sandwiched between a #1 coverslip and a microscope 
slide using double-sided adhesive (Grace Biolabs). The total ear thickness was less than 400 μm. The 
sample was placed on the stage of the SRS microscope and images were recorded as described below. 
SRS Imaging. The SRS microscope was similar to one described previously,4 and consisted of a 
picosecond-pulsed laser system pumping a modified laser scanning microscope optimized for SRS 
imaging. The laser system was based on a mode-locked Nd:YVO4 laser (picoTrain, High Q Laser) that 
delivered 7 ps pulses at a repetition rate of 76 MHz with an average power of ~18W at 1064 nm. A 
portion of the fundamental output was used as the Stokes beam. The remainder of the output was 
frequency doubled and 6W of light at 532 nm was used to synchronously pump an optical parametric 
oscillator (OPO; Levante Emerald, APE GmbH). The OPO signal wave output was employed as the pump 
beam and was tunable from 680 nm to 1000 nm, allowing coverage of the vibrational spectrum from 600 
cm-1 to >4000 cm-1 when combined with the 1064 nm Stokes beam. The spectral width in both beams 
was ~0.3 nm. The OPO was tuned using the integrated control electronics which allow the nonlinear 
crystal temperature, intra-cavity tuning element and cavity length to be adjusted with computer control.  
The Stokes beam output passed through an electro-optic modulator based on a pair of rubidium 
titanyl phosphate crystals (Raicol Crystals, Ltd.), to which a high voltage sinusoidal drive waveform at 10 
MHz was applied. The modulator, in combination with a polarization analyzer, provided amplitude 
modulation of the Stokes beam with ~100% modulation depth at the 10 MHz drive frequency. The 
Stokes beam and pump beam were combined on a dichroic mirror (DM; 1064dcrb, Chroma Technology) 
after the Stokes beam was delayed so that the two pulse trains temporally and spatially overlap after the 
DM. The combined beams were aligned into a modified upright laser scanning microscope 
(BX61WI/FV300, Olympus) with high near-infrared throughput. The two beams were focused into the 
sample (described above) using a water immersion objective lens (UPlanSApo 60X 1.2NA, Olympus) and 
scanned in two dimensions using a pair of galvanometer mirrors. The transmitted laser beams were 
collected using a high numerical aperture condenser (1.4NA, Nikon) and relayed using a pair of lenses 
onto a large-area photodiode (FDS1010, Thorlabs). An optical filter (CARS890/220, Chroma Technology) 
in front of the photodiode blocked the Stokes beam and transmitted the pump beam. The photodiode 
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was back-biased through a passive bandpass filter (BLP-1.9, Minicircuits) and the photocurrent was 
bandpass-filtered (BBP-10.7, Minicircuits) and fed in to a lock-in amplifier (SR844, Stanford Research 
Systems) for demodulation. The lock-in amplifier output, which was proportional to the SRS signal, was 
routed into the analog input of the microscope scan controller and displayed onscreen using the control 
PC and software (FV5, Olympus). Depth stacks were obtained by controlled movements of the objective 
lens using a stepper motor under control of the scan software.  
Data Analysis. After data acquisition, three-dimensional images were analyzed using Igor Pro 
(Wavemetrics). The datasets were manually registered based on the appearance of the individual images 
and similar regions of interest were integrated to obtain the intensities as function of depth and location. 
For presentation of the image stacks, linear look-up tables were applied with different false color 
schemes to represent different Raman shifts. 
 
 
Results & Discussion 
First, a ketoprofen solution in deuterated PG was applied ex vivo to an excised piece of mouse 
ear, which was subsequently sealed between two coverslips and placed on the SRS microscope stage. 
Three-dimensional volumes of SRS data were then acquired over an area of approximately 250 x 250 µm2 
and to a depth of ~100 µm. The images obtained extended from within the drug-in-solvent layer above 
the skin down to the subcutaneous fat. The lipid architecture was first mapped from a series of images 
based on the CH2 stretching absorbance at 2845 cm
-1.  Attention was focused on the major barrier to skin 
penetration of chemicals, the SC (the outermost ~15 µm of the skin) which comprises tightly packed 
layers of terminally differentiated, keratin-filled corneocytes (roughly hexagonal in shape, ~20 µm across, 
yet only ~0.5 µm in thickness), the spaces between which are filled with a mixture of lipids organized into 
lamellar bilayers. SRS delineated individual cells clearly via the CH2 signal emanating from the 
intercellular lipids (Figure 2) in the images recorded from different depths (Z), indicated down the left 
side of the figure, at the beginning (t = 11 minutes post-application of the ketoprofen in PG solution) and 
end (t = 158 minutes) of the penetration experiments.  Registration of images to the same tissue region 
is possible, an attribute thereby permitting useful and novel mechanistic information to be deduced.  An 
off-resonance image taken after the final CH2-stretching dataset shows no signal, demonstrating the 
label-free contrast and chemical selectivity of SRS. When the pump laser is tuned off-resonance (i.e., 
away from the CH2 stretching absorbance frequency), the signal level drops to the background which is 
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<1% of the peak CH2 signal (and <5% of the peak signal from PG-d8 discussed below), making the image 
effectively black and featureless. This outcome highlights a major advantage of SRS over the related 
coherent anti-Stokes Raman scattering (CARS) technique for which strong background signals from tissue 
complicate data analysis4.   
 
Figure 2: Architecture of mouse skin based on SRS imaging.  Images at t = 11 and 158 minutes are 
acquired with CH2-stretching contrast and show the lipid architecture of the skin at various depths. The 
off resonance images demonstrate the chemical contrast of SRS.  Scale bar = 50 μm.   
Then, on the same tissue sample, the laser was tuned either to the aromatic CH stretching 
absorbance frequency, or to the CD2 (carbon-deuterium) stretching band to visualize ketoprofen and PG, 
respectively. Because it was possible to recognize individual cells in the skin, the 3-dimensional stacks 
could be registered to minimize the impact of drift and swelling of the tissue. This meant that changes in 
signal from the topically applied chemicals, as a function of depth within the SC, could be visualized 
throughout the experiment. Such time lapse images for deuterated PG and ketoprofen are in Figure 3.  
The image series at the skin surface (Z = 0 μm) shows minimal changes in intensity because the chemical 
concentrations above the tissue do not change significantly during the experiment. In contrast, images in 
the stratum corneum (Z = 12 and 15 μm) show increasing signal over time. The data acquisition time in 
these experiments was about 20 seconds per frame (256 x 256 pixels). Each stack of images from the skin 
surface to the deeper layers of the tissue therefore required about 10 minutes to acquire. Alternating 
stacks of images from the drug and from the cosolvent were obtained by re-tuning the laser between 
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each stack. It is apparent that both compounds penetrate via the intercellular lipids of the stratum 
corneum and, as well, through the hair shafts. Only by 3-dimensional resolution of the penetration maps 
is this type of direct mechanistic insight achievable, and other analytical techniques, including those 
based on spontaneous Raman scattering, lack sufficient spatiotemporal resolution for these 
measurements.  
 
 
Figure 3: Imaging the penetration of deuterated PG (upper panel) and ketoprofen (lower panel) across 
the stratum corneum. Images acquired at the depths indicated down the left-hand side of the figure and 
times indicated along the top show the penetration of cosolvent and drug into the tissue using SRS 
contrast at 2120 cm-1 and 1599 cm-1, respectively.  Scale bar = 50 μm.   
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Next, integration of the total signal as a function of depth from the registered 3-dimensional 
maps provided an effective concentration profile of the penetrating species.  A representative result for 
deuterated PG as a function of time post-application of the formulation is in Figure 4A.  Experimental 
data points were obtained by integrating comparable regions of interest in Figure 3. The relative amount 
of PG, as a function of position within the skin, at each time, is determined by the ratio of the integrated 
total signal at each depth to that at the surface (located at approximately Z = 0 μm).  Thus, each 
normalized profile decreases from a value of 1 at the surface with increasing distance of penetration into 
the skin. Normalization of the profiles to 1 at the top layer assumes that the chemical’s concentration 
above the sample does not change significantly during the experiment (a reasonable approximation 
given the effectively infinite ‘dose’ of solution applied at t = 0). Monotonically-increasing penetration 
profiles over time are observed; that is, the area under the normalized signal versus distance profiles 
increases as more of the cosolvent is absorbed into the SC.      
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Figure 4:  Integrated depth-profiling analysis of percutaneous penetration. (A) Depth profiles of 
deuterated PG as a function of time. (B) Comparison of the areas under the normalised SRS signal versus 
skin depth profiles (AUCs) of PG and ketoprofen at different times (26 and 104 minutes, and 34 and 134 
minutes, respectively) post-application of the formulation (left-hand y-axis).  The ratios of the AUCS 
(right-hand y-axis) determined after the first and last measurements (at approximately 0.5 and 2 hours) 
demonstrate the slower penetration rate of the drug compared to that of the cosolvent. 
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Data obtained nearly simultaneously from ketoprofen showed similar behavior, although the 
slower rate of change of the normalized signal versus distance profile with increasing time demonstrated 
that PG penetrates the stratum corneum more efficiently than the drug (Figure 4B).  This finding is 
consistent with tape-stripping and attenuated total reflectance infrared spectroscopy experiments that 
tracked the uptake of ibuprofen and PG into human SC9-12, and emphasises the importance of tracking 
not only the drug when attempting to understand the performance of a topical formulation.13  The 
temporal evolution of the effective concentration profiles in Fig. 2A and their monotonic decrease from 
the skin surface into the barrier are both qualitatively and quantitatively comparable with data from the 
far more invasive and labor-intensive tape-stripping results observed previously9,11,12, and suggest a 
diffusion lag-time on the order of 2 hours.  More refined interpretation of these results will be possible 
with the acquisition of SRS images in finer steps (e.g., 1 µm, rather than every 3 µm), and an improved 
use of the CH2 signal to define SC thickness. 
A major challenge in analyzing the 3-dimensional datasets presented here is to extract truly 
quantitative information from the images. Spatial drift and swelling of tissue over the time course of the 
experiment mean that the three-dimensional datasets must be registered with care in order to separate 
tissue movement from diffusion of the compounds of interest within the skin. In this work, this is 
achieved by visual inspection which permits linear 3-dimensional movements to be taken into account 
but cannot remove distortions or swelling of the tissue. In addition, the penetration of compounds, such 
as PG, can affect the linear optical properties of the tissue, affecting the depth profiles by changing signal 
levels because of alterations in laser power at the focus rather than changes in chemical concentration14. 
Recent reports of optical clearing measurements in microscopy suggest that these linear optical property 
changes are relatively rapid (they occur in ~30 minutes),15 so that the measurements reported here, 
which began at 26 minutes post-initiation of the experiment, should not be significantly affected. 
Nevertheless, developing methods to compensate for the changing linear optical properties of tissue will 
improve quantitative analysis. Additionally, improving the imaging speed7 will ultimately allow 
experiments to be conducted in vivo, where high speed imaging is a requirement because living samples 
inevitably move on the microscopic length scale, and result in blurred images if the acquisition speed is 
too low. 
A further illustration of the ability of SRS microscopy to track chemical uptake and transport 
kinetics across the SC is illustrated in Figure 5A, which plots the normalized, integrated signal from PG at 
12 and 15 µm from the skin surface (note that, in this case, the data have been normalized such that the 
 11 
final value is equal to 1 so as to better visualize the overall trends with time).  The significant increase in 
cosolvent level in deeper tissue layers with increasing time is clearly shown; in contrast, the relative 
signal at the skin surface (Z = 0 µm) did not change, reflecting the essentially infinite dose of formulation 
applied. 
A B
 
Figure 5: (A) Temporal profiles of the signal intensity from PG at the skin surface (Z = 0 μm) and at two 
representative depths (12 and 15 µm) into the skin. (B) Temporal profiles of PG at a depth of Z = 6 μm at 
two specific sub-regions of the images. The green trace corresponds to the area shown in the inset image 
enclosed by the green box that surrounds a hair shaft. The red trace corresponds to the area in the inset 
image enclosed by the red box that surrounds several corneocytes.  
In addition, the three-dimensional imaging capability provided novel mechanistic insight into the 
topical drug delivery process (an achievement impossible with Raman depth profiling16,17 or tape 
stripping2,9,11,12 which are essentially one-dimensional techniques). Specifically, Figure 5B compares the 
penetration profile of deuterated PG via a hair shaft to that via the SC intercellular lipids (outlined 
respectively in the inset of Figure 5B by the green and red boxes). These results were generated by 
integrating the signal from two regions of interest, one a clearly visible follicle, the other an area 
encompassing the basket-weave structure typical of SC, at the same depth, as a function of time. While 
the signal from SC steadily increased with time, that from the hair shaft remained essentially unchanged 
and, importantly, significantly above background. Thus, PG penetration via the hair shaft was rapid and 
attained steady-state before the first measurement was recorded at 26 minutes post-application of the 
formulation.  On the other hand, transport through the SC intercellular lipids was slower and the 
increasing signal over time during the ~2-hour experiment represented the non-steady state approach to 
a constant flux. These data provide direct experimental proof of behavior deduced over 40 years ago by 
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Scheuplein18,19 who inferred that the initial drug molecules crossing the skin post-treatment came 
through low-resistance, “shunt” pathways (such as hair shafts) of limited capacity; the parallel, but 
slower, transport across the bulk of the SC eventually overwhelms the transient pathways, however, and 
completely dominates at steady-state.  Despite additional, indirect support for the importance of the 
follicular pathway,20,21 the SRS microscopy data in Figure 5B are unique in their separation and real-time 
observation of molecular transport at two distinct rates occurring through two discrete and identifiable 
pathways across the skin.  
In a final series of measurements, the apparently rapid penetration of the cosolvent, relative to 
that of drug (Figure 4B), was probed following topical application of deuterated ibuprofen in ‘normal’ 
(i.e., undeuterated) PG. The drug concentration in the cosolvent represented about 90% of its saturation 
solubility9.  Less than 30 minutes post-application, the formation of solid ibuprofen crystals (with 
characteristic sizes of tens of microns - see Figure 6A), which produced a strong Raman signal at the CD 
stretching frequency, was observed at the skin surface (Figure 6B) on the SC (Figure 6C). Some drug 
penetration via the follicular “shunt” route was again seen (inset in Figure 6B).  The logical explanation 
for the precipitation of ibuprofen observed is that the faster penetration of PG into the skin (coupled, 
perhaps, with some evaporation from the surface) caused the drug concentration to increase above its 
saturation solubility.  Again, while this phenomenon has been anticipated, and for which indirect 
evidence has been obtained,10 the 3-dimensional SRS imaging illustrated in Figure 6 represents new and 
direct proof of the so-called “metamorphosis”22-24 of a topical drug formulation post-application to the 
skin.  
In summary, this SRS microscopy study of dermato-pharamacokinetics has revealed previously 
invisible features of the percutaneous penetration of skin-active compounds. As a label-free optical 
imaging technique, SRS permits non-destructive visualization of the drugs and excipients delivered from 
topically-applied formulations with high spatial and temporal resolution. The application of SRS to the 
delivery of ketoprofen and ibuprofen has unambiguously revealed distinct penetration pathways, across 
which the molecules transport at different rates, and has directly visualized the formation of drug 
crystals on the tissue surface in situ during the initial stages of the penetration process. Improved image 
acquisition speed, signal processing and analysis – especially in terms of defining more precisely the 
location of the skin surface - will allow further quantitative information to be extracted, and the 
technology may ultimately be applied in vivo (in models more relevant than the mouse skin used in this 
 13 
work) to understand and optimize formulations and delivery vehicles for topical and transdermal drug 
delivery. 
 
 
Figure 6: Crystal formation on the skin surface 25 minutes post-topical application of a solution of 
ibuprofen in PG. (A) Maximum intensity depth projection (of the upper ~30 μm) with SRS contrast at 2120 
cm-1. (B) Depth projection down the yellow dotted line in panel (A) again showing contrast for deuterated 
ibuprofen. Crystal formation on the tissue surface and some penetration down the hair shaft (inset) are 
seen. (C) CH2-stretching image from the same region showed the bright SC and very clear contrast from 
the undeuterated PG above the SC.  Scale bar = 50 μm. 
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